Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | ABCC1 | P33527 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | POLB | P06746 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14374144 | 0.79 | HPGD (0.62) | ATMABCC1HPGDTSHRALDH1A1 | |
| SCHEMBL1001922 | 0.79 | HPGD (0.62) | ATMABCC1HPGDTSHRALDH1A1 | |
| SCHEMBL4359670 | 0.77 | HPGD (0.59) | ATMABCC1HPGDTSHRALDH1A1 | |
| SCHEMBL20414332 | 0.75 | ATM (0.50) | ATMABCC1LMNAMAPTHPGD | |
| SCHEMBL8638472 | 0.72 | ALDH1A1 (0.48) | ATMMAPTHPGDALDH1A1KMT2A | |
| SCHEMBL14999390 | 0.72 | ALDH1A1 (0.48) | ATMMAPTHPGDALDH1A1KMT2A | |
| SCHEMBL20419616 | 0.72 | ALDH1A1 (0.48) | ATMMAPTHPGDALDH1A1KMT2A | |
| SCHEMBL9001768 | 0.71 | POLB (0.62) | ATMHPGDTSHRALDH1A1KMT2A | |
| SCHEMBL11047555 | 0.71 | SIGMAR1 (0.45) | ATMLMNAMAPTTSHRALDH1A1 | |
| SCHEMBL14373102 | 0.71 | ATM (0.50) | ATMABCC1LMNAMAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11545637-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-01-03 | — | — | US | disclosed |
| US-20180212163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2018-07-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180212163-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD2, OCIAD1, ICOSLG | ATM 3200/4885ABCC1 4176/4885LMNA 4114/4885 |
| US-11545637-B2 | Organic electroluminescent materials and devices | OCIAD2, OCIAD1, ICOSLG | ATM 3200/4885ABCC1 4176/4885LMNA 4114/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.